Your browser doesn't support javascript.
loading
Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients.
Betof Warner, Allison; Tarhini, Ahmad; Kang, Barinder; Nakasato, Antonio; Ling, You-Li; Shah, Rohan; Tang, Jackson; Patel, Jeetvan.
Afiliación
  • Betof Warner A; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
  • Tarhini A; Cutaneous Oncology and Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Kang B; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Nakasato A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Ling YL; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Shah R; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Tang J; Asclepius Analytics Ltd., New York, New York, USA.
  • Patel J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Melanoma Res ; 33(1): 38-49, 2023 02 01.
Article en En | MEDLINE | ID: mdl-36545921
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article